ACADIA Pharmaceuticals's total assets for Q1 2025 were $1.13B, a decrease of -4.66% from the previous quarter. ACAD total liabilities were $367.13M for the fiscal quarter, a -19.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.